Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to -$3.52.

  • Sanara MedTech's EPS (Basic) fell 93529.41% to -$3.52 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.34, marking a year-over-year decrease of 33838.38%. This contributed to the annual value of -$1.16 for FY2024, which is 11586.63% down from last year.
  • Sanara MedTech's EPS (Basic) amounted to -$3.52 in Q3 2025, which was down 93529.41% from -$0.23 recorded in Q2 2025.
  • Sanara MedTech's EPS (Basic)'s 5-year high stood at $0.1 during Q2 2022, with a 5-year trough of -$3.52 in Q3 2025.
  • Its 5-year average for EPS (Basic) is -$0.45, with a median of -$0.23 in 2025.
  • As far as peak fluctuations go, Sanara MedTech's EPS (Basic) skyrocketed by 16250.0% in 2022, and later tumbled by 250382.91% in 2024.
  • Sanara MedTech's EPS (Basic) (Quarter) stood at -$0.48 in 2021, then decreased by 9.7% to -$0.53 in 2022, then surged by 93.98% to -$0.03 in 2023, then tumbled by 2503.83% to -$0.83 in 2024, then plummeted by 326.45% to -$3.52 in 2025.
  • Its EPS (Basic) stands at -$3.52 for Q3 2025, versus -$0.23 for Q2 2025 and -$0.41 for Q1 2025.